Showing 2701-2710 of 5065 results for "".
Physician Spotlight: J. Matthew Knight, MD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-j-matthew-knight-md-faad/20561/Dermatologists must act now to extinguish burnout or risk dire consequences.Meet the New Crop of Pigment Correctors
https://practicaldermatology.com/topics/pigmentary-disorders/meet-the-new-crop-of-pigment-correctors/23767/Hydroquinone is no longer the only game in town. In fact, alternatives are now more readily available and show good efficacy.Currents: Practice Development Trends
https://practicaldermatology.com/topics/practice-management/currents-practice-development-trends/20415/Practice Development Trends7 Ways to Create the Ultimate Patient Experience
https://practicaldermatology.com/topics/practice-management/7-ways-to-create-the-ultimate-patient-experience/23799/Dear New Resident; CSF Grants Available
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dear-new-resident-csf-grants-available/20458/Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.Revisiting Facial Seborrheic Dermatitis: A New Therapeutic Option
https://practicaldermatology.com/topics/general-topics/PD0109_05-php/22892/A popular topical agent offers anti-inflammatory, antibacterial, and sebosuppressive effects that could prove useful for management of seborrheic dermatitis.Guiding Patients to Good Skincare
https://practicaldermatology.com/topics/practice-management/guiding-patients-to-good-skincare/20577/A skincare pyramid offers physicians a tool to engage and educate patients about anti-aging skincare options from prevention to reversal.SPF Recommendations: Should They Change?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/spf-recommendations-should-they-change/21475/What is the minimum SPF dermatologists should be recommending to their patients?Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.